Recombinant terminal deoxynucleotidyl transferase with improved functionality
View Patent ↗Truncated terminal deoxynucleotidyl transferase (TdT) derivative from calf thymus, characterized in that the derivative in comparison to the native TdT is N-terminally truncated by up to 161 amino acids and has a 20- to 30-fold higher enzyme activity in solutions containing Co 2+ ions, and its recombinant production and use.
1. A recombinantly expressed terminal deoxynucleotidyl transferase (TdT) fusion protein comprising a truncated terminal deoxynucleotidyl transferase sequence and a protein tag sequence N-terminally fused to said truncated terminal deoxynucleotidyl transferase sequence, wherein said protein tag is selected from the group consisting of a His tag, Streptavidin binding proteins, Maltose binding proteins, GST and HA tags, and wherein the truncated terminal deoxynucleotidyl transferase sequence consists of the native calf thymus TdT sequence of SEQ ID NO: 2 N-terminally truncated by 138, 152, or 161 amino acids, wherein said recombinantly expressed terminal deoxynucleotidyl transferase fusion protein has a 20- to 30-fold higher enzyme activity in solutions containing Co2+ ions relative to solutions containing Zn/Mg ions.
2. A recombinantly expressed terminal deoxynucleotidyl transferase (TdT) fusion protein comprising a truncated terminal deoxynucleotidyl transferase sequence and a protein tag sequence N-terminally fused to said truncated terminal deoxynucleotidyl transferase sequence, wherein said protein tag is selected from the group consisting of a His tag, Streptavidin binding proteins, Maltose binding proteins, GST and HA tags, and wherein the truncated terminal deoxynucleotidyl transferase sequence consists of the native calf thymus TdT sequence of SEQ ID NO: 2 N-terminally truncated by 100 to 160 amino acids, wherein said recombinantly expressed terminal deoxynucleotidyl transferase fusion protein has a 20- to 30-fold higher enzyme activity in solutions containing Co2+ ions relative to solutions containing Zn/Mg ions.
3. The recombinantly expressed terminal deoxynucleotidyl transferase fusion protein of claim 1 , wherein the truncated terminal deoxynucleotidyl transferase sequence is shortened at the N-terminus by 138 amino acids, has a molecular weight between 44 and 46 kDa (SDS page) and has a 20- to 25-fold increased enzyme activity in solutions containing Co2+ ions compared to native TdT.
4. A composition comprising a homogenous population of a recombinantly expressed terminal deoxynucleotidyl transferase (TdT) fusion protein, wherein the recombinantly expressed terminal deoxynucleotidyl transferase comprises a truncated terminal deoxynucleotidyl transferase sequence and a His tag sequence N-terminally fused to said truncated terminal deoxynucleotidyl transferase sequence, wherein said truncated terminal deoxynucleotidyl transferase sequence consists of the sequence of SEQ ID NO: 2 N-terminally truncated by at least 100 amino acids and up to 160 amino acids, wherein said recombinantly expressed terminal deoxynucleotidyl transferase fusion protein has a 20- to 30-fold higher enzyme activity in solutions containing Co2+ ions relative to solutions containing Zn/Mg ions.
5. The composition of claim 4 wherein the truncated terminal deoxynucleotidyl transferase sequence consists of the sequence of SEQ ID NO: 2N-terminally truncated by 138 amino acids.
6. The composition of claim 4 wherein the truncated terminal deoxynucleotidyl transferase sequence consists of the sequence of SEQ ID NO: 2 N-terminally truncated by 152 amino acids.
7. The recombinantly expressed terminal deoxynucleotidyl transferase fusion protein of claim 1 wherein the truncated terminal deoxynucleotidyl transferase sequence consists of the sequence of SEQ ID NO: 2 N-terminally truncated by 161 amino acids.
8. The recombinantly expressed terminal deoxynucleotidyl transferase fusion protein of claim 1 wherein said protein tag sequence is a (poly) histidine peptide.
9. The recombinantly expressed terminal deoxynucleotidyl transferase fusion protein of claim 8 wherein said His tag consists of the sequence Met-Arg-Gly-Ser-His-HiS-His-His-His-His (SEQ ID NO: 14).
10. The composition of claim 4 wherein the recombinantly expressed terminal deoxynucleotidyl transferase fusion protein consists of a polypeptide selected from the group consisting of SEQ ID NO: 8 and SEQ ID NO: 16.
11. The recombinantly expressed terminal deoxynucleotidyl transferase (TdT) fusion protein of claim 1 , wherein the recombinantly expressed terminal deoxynucleotidyl transferase fusion protein consists of the polypeptide of SEQ ID NO: 18.